Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as
Previous Article
What... )t'naC yehT tahW dna( oD naC s
Next Article
What... ?uoy tuoba laever sserdda PI r